Physical Compatibility Between Intravenous Magnesium Sulfate and Potassium or Sodium Phosphate in a Pediatric Intensive Care Unit
- 15 April 2024
- journal article
- research article
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 59 (5) , 557-561
Abstract
Objective:To evaluate the physical compatibility between intravenous magnesium sulfate and potassium and sodium phosphate, a common electrolyte intravenous supplementation in pediatric intensive care units. Study design: Magnesium sulfate was mixed separately with potassium phosphate and sodium phosphate at ratios of 1:1, 1:4, and 4:1. Binary mixtures were prepared, in triplicate and under sterile conditions, by permuting the order of addition. The undiluted pure drugs were used as controls for possible sequence effects. Visual changes, turbidity, and pH were assessed immediately after mixing (baseline) and at 4 and 24 hours. Two observers performed visual changes by naked-eye visual inspection in order to search visible haze, particulate matter, gas formation, or color change. Turbidity was measured by nephelometry and incompatibility was defined as an increase of ≥0.5 nephelometric turbidity units (NTU) from baseline. pH was measured using a portable pH meter and incompatibility was defined as a variation of >1 pH unit during the observation period. Results: None of the admixtures exhibited visual changes or significant variations in turbidity (increases of ≥0.5 in nephelometric turbidity units) or pH (changes of >1 unit) during the observation period and neither compared with baseline. Conclusion: In this study, no visual changes were observed, and turbidity and pH evaluated by instrumental methods remained within acceptable limits and showed no significant variations from baseline, therefore no physical incompatibility between magnesium sulfate and potassium or sodium phosphate was found.Keywords
This publication has 11 references indexed in Scilit:
- Difficult intravenous access in a paediatric intensive care unitEnfermería Intensiva, 2022
- Vía venosa difícil en una unidad de cuidados intensivos pediátricosEnfermería Intensiva, 2022
- Compatibilidad de los fármacos administrados en «Y» en las unidades de cuidados intensivos: revisión sistemáticaMedicina Intensiva (English Edition), 2020
- Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride BagsThe Canadian Journal of Hospital Pharmacy, 2017
- Y-site Incompatibility between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?Hospital Pharmacy, 2017
- Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugsNutrition Journal, 2015
- Mixing medicines: how to ensure patient safetyPharmaceutical Journal, 2015
- Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemideEuropean Journal of Hospital Pharmacy, 2014
- Drug incompatibility chemistryAmerican Journal of Health-System Pharmacy, 2009
- Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2American Journal of Health-System Pharmacy, 1981